Novel nonsecosteroidal vitamin D(3) carboxylic acid analogs for osteoporosis, and SAR analysis.
Kashiwagi, H., Ono, Y., Shimizu, K., Haneishi, T., Ito, S., Iijima, S., Kobayashi, T., Ichikawa, F., Harada, S., Sato, H., Sekiguchi, N., Ishigai, M., Takahashi, T.(2011) Bioorg Med Chem 19: 4721-4729
- PubMed: 21795053 
- DOI: https://doi.org/10.1016/j.bmc.2011.07.001
- Primary Citation of Related Structures:  
3AZ1, 3AZ2, 3AZ3 - PubMed Abstract: 
Novel vitamin D(3) analogs with carboxylic acid were explored, focusing on a nonsecosteroidal analog, LG190178, with a bisphenyl skeleton. From X-ray analysis of these analogs with vitamin D receptor (VDR), the carboxyl groups had very unique hydrogen bonding interactions in VDR and mimicked 1α-hydroxy group and/or 3β-hydroxy group of 1α,25-dihydroxyvitamin D(3). A highly potent analog, 6a, with good in vitro activity and pharmacokinetic profiles was identified from an SAR study. Compound 6a showed significant prevention of bone loss in a rat osteoporosis model by oral administration.
Organizational Affiliation: 
Research Division, Chugai Pharmaceutical Co. Ltd, 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan. kashiwagihrt@chugai-pharm.co.jp